浅析阿奇霉素药典标准提高与药品生产工艺的关系
被引量:3
Discussion between Improved Standard and Productive Process of Azithromycin
摘要
近年来,随着新型仪器设备的普及和科研投入的增大,我国药物标准的提高工作也越来越深人。《中国药典》中药品标准提高不但减少了原料药、注射剂等药品中的杂质含量和保证安全用药,而且对于药品的生产具有间接的指导作用,对于淘汰老旧工艺,促进技术革新和工艺改进有不可估量的意义。
出处
《中国药品标准》
CAS
2012年第2期83-86,共4页
Drug Standards of China
参考文献11
-
1中国药典[s].二部,2010:附录88-89.
-
2阿奇霉素氯化钠注射液国家药品标准[s].修订件XGB2007.009.
-
3欧洲约典[S].6.0版.1434-1436.
-
4美国药典[S].30版.2007:283-283.
-
5Kobrebel G, Radobolja G, Tamburasev Z. 11-Aza-10-Deoxo-10- Dihydro erythromyein A and Derivatives Thereof as Well as a Process for Their Preparation[ P]. US4328334, 1982-05-04.
-
6Yang B V. Intermediate for azithromycin [ P ]. WO9426758, 1994-11-24.
-
7Bright G M. N-Methyl 11-aza-10-deoxo-10-dihydro-e~|mmyein A, intermediates therefor[ P]. US 4474768, 1984-11-15.
-
8姜建国,张西茹,杨梁,吴如金.阿奇霉素中相关物质的分离和鉴定[J].药物分析杂志,2004,24(6):580-584. 被引量:3
-
9孟涛,马敏,姚国伟.红霉素肟贝克曼重排反应中的构型异构化[J].精细化工,2007,24(4):376-379. 被引量:5
-
10Chen S L, Bhattacharjee A, Duffy E M. Macrolide compaum]s and methods of making and using the same [ P ]. W02008143729 , 2008-11-27.
二级参考文献9
-
1马敏,姚国伟,史颖,邓玉林.阿奇霉素合成工艺的改进[J].精细化工,2006,23(8):781-783. 被引量:10
-
2Drug Specifications Promulgated by Ministry of Public Health, P R China(Trial) [中华人民共和国卫生部部标准(试行)]. WS -256(X-221) -96
-
3Barber J. Assignments of the carbon - 13 and proton of azithromycin in trichloromethane - d. Magn Reson Chem, 1991,29 (7) :740
-
4Bright GM,Nagel A A,Bordnor J,et al.Synthesis,in vivo activity of novel 9-deoxo-9a-aza-homo erythromycin A derivatives:a new class of macrolide antibiotics,the azalides[J].J Antibiot,1988,41(8):1029-1047.
-
5Gabrijela Kobrebel,Gordana Radobolja,Zrinka Tamburasev.11-Aza-10-deoxo-10-dihydro erythromyicn A and derivatives thereof as well as a process for their perparation[P].US:4 328 334,1982.
-
6Djokic S,Kobrehel G,Lazarevski G.Erythromycin series.Part 11.Ring expansion of erythromycin A oxime by the Beckmann rerrangment[J].J Chem Soc:Perkin Trans 1,1986:1881-1890.
-
7Gabrijela Kobrebel,Slobodan Djokic.11-Methyl-11-aza-4-o-clad-inosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one and derivatives thereof[P].US:4 517 359,1985.
-
8Bingwei V Yang.Intermediates for azithromycin[P].WO:9 426 758,1994.
-
9Robert R Wilkening,Ronald W Ratcliffe,George A Doss.The synthesis of novel 8a-aza-8a-homo erythromycin derivatives via the Beckmann rearrangement of (9z)-erythromycin A oxime[J].Organic & Medicinal Chemistry Letters,1993,3(6):1287-1292.
共引文献47
-
1王建,王巧群,孙进,倪坤仪,肖莹.硫酸异帕米星中有关物质的分离、鉴定和抗菌活性研究[J].中国药学杂志,2007,42(2):150-154. 被引量:4
-
2李峰,陈辉.红霉素肟合成工艺研究[J].河南化工,2008,25(8):26-27. 被引量:1
-
3李海华,武春亮,张雪梅,哈里玛.红霉素6,9-亚胺醚制备的工艺研究[J].广东化工,2008,35(11):13-16. 被引量:2
-
4赵佳苗,施介华,许超.阿奇霉素及其关键中间体的合成研究进展[J].化工技术与开发,2009,38(4):28-34. 被引量:6
-
5邰新丽,李建华,陈阳,汪杨,陈桂良.不同厂家复方酮康唑乳膏释放度的比较[J].中国药事,2009,23(5):474-476. 被引量:7
-
6王岩,张启明.进口药品质量标准复核中常见技术问题的探讨[J].中国药事,2010,24(7):662-665. 被引量:2
-
7潘士印,肖湘华,王养正,银勇,朱秀萍.HPLC与微生物检定法测定阿奇霉素滴眼液含量的比较研究[J].西北药学杂志,2011,26(3):177-179. 被引量:4
-
8钱丽萍,阙慧卿,林绥,彭华毅,郭舜民.雷公藤贴剂中雷公藤内酯醇释放度的测定[J].现代药物与临床,2011,26(5):403-405. 被引量:4
-
9贺学锋,陈玉武.关于乙酰螺旋霉素制剂四个组分总含量测定结果计算公式的修改建议[J].北方药学,2012,9(2):4-5.
-
10陈勇,陆静娴,周建良,祝明.薏苡仁对照药材和薏苡仁油对照提取物稳定性考察[J].中国药品标准,2012,13(1):39-40. 被引量:4
同被引文献27
-
1谢沐风.薄层色谱法检测有关物质时存在的问题[J].中国医药工业杂志,2005,36(10):651-652. 被引量:6
-
2中国药典[S].2010年版.二部.附录ⅨJ.
-
3美国药典[S].37版.2752.
-
4英国药品委员会.英国药典[s].TheStationeryoffice出版社,2014.1059.
-
5ZHANG LING, SONG LINCHEN, LIU ZHAOPENG, et al. Synthesis and antibacterial activity of novel 3-O-carbamoyl de- rivatives of clarithromycin and 11,12-cyclic carbonate azithro- mycin[J]. European Journal of Medicinal Chemistry, 2010,45(3):915-918.
-
6ALIHODZIC, SULEJMAN, STARCEVIC KRISTINA, et al. 3-N-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin Having Antimalarlal Activity ~ WO, 2010086351 [P]. 2010 -- 08-- 05.
-
7KRISTINA STARCEVIC, DIJIANA PESIC, ANA TOPLAK, et al. Novel Hybrid Molecules Based on 15-membered as Po- tential Antimalarial Agens[J]. European Journal of Medicinal Chemistry, 2012,49 (2) :365-369.
-
8覃鹏,吴忠,张俊山,等.阿奇霉素或阿奇霉素的中间体脱去克拉定糖化合物的制备工艺:中国,201310125166[P].20130807.
-
9BURNET MICHAEL, GUSE JAN-HINRICH, GUTKE HANS JURGEN, et al. Conjugates Of Biologically Active Compounds, Methods For Their Preparation And Use, Formulation And Pharmaceutical Applications Thereof: WO, 2003070174 [P]. 2003--08--28.
-
10GUSE JAN-HINRICH, BAEUERLEIN CHRISTIANE, EGG- ERS MARY, et al. Anti-inflammatory Macrolides: WO, 2012051126[P]. 2012--04--19.
引证文献3
-
1李亚林,苏永青,张志霞.去克拉定糖阿奇霉素的合成研究[J].石家庄职业技术学院学报,2015,27(4):9-14.
-
2李亚林,苏永青,张志霞.3′-N-去甲基阿奇霉素的合成研究[J].石家庄学院学报,2015,17(6):20-24.
-
3耿颖,程奇蕾,刘朝霞,何兰.《中国药典》2010年版布洛芬原料及制剂有关物质标准提高的探讨[J].中国药品标准,2015,16(5):334-335.
-
1毕飞霞,梅华,张荣,郝晓芳.几种药品标准中胆酸显色反应存在的问题[J].中成药,1997,19(6):46-47.
-
2欧盟行将制定统一药物标准[J].中医药信息月报,2003(2):19-19.
-
3袁沙,国圜.地方标准提高为部颁标准的中成药质量管理[J].华西药学杂志,1998,13(3):211-212.
-
4“机制探讨”征稿启事[J].中国针灸,2010,30(2):159-159.
-
5“机制探讨”征稿启事[J].中国针灸,2009,29(12):1028-1028.
-
6“机制探讨”征稿启事[J].中国针灸,2009,29(7):520-520.
-
7王彧丽,梅泽芬.刍议中药饮片质量[J].中国药业,1998,7(6):49-49.
-
8坎买尔丁·沙木沙克.雄黄的维吾尔医炮制法及其治疗作用[J].新疆维吾尔医学专科学校学报(维文),2016,26(4):83-86.
-
9国家调整对中药科研投入方向中药基础研究成为重点[J].中药研究与信息,2002,4(2):60-60.
-
10王勇,卢端萍.国家中药标准提高行动计划[J].海峡药学,2003,15(6):96-99.